ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710204 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710204; 2) Community: the network communities that were significantly associated with the response to NSC 710204; 3) Molecule: the relationships between components within communities and NSC 710204; 4) MDR: the compounds that were significantly associated with the NSC 710204.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.00426229108513041 0.43000298
NSC 300289 Pinafide 0.00426229108513041 0.33101063
NSC 339137 PHYSALOLACTONE 0.00426229108513041 0.54892564
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.00426229108513041 0.43880008
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.00426229108513041 0.15767889
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.00426229108513041 0.46366416
NSC 371777 Null 0.00426229108513041 0.24831386
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00426229108513041 0.43661937
NSC 624657 ANTINEOPLASTIC-624657 0.00426229108513041 0.30547656
NSC 637411 Null 0.00426229108513041 0.19338392
Total:135  Current:25    [First] [Prev] [Next] [Last]